1 min read
Add as a preferred source on GoogleAstraZeneca Cuts About 600 Marketing Jobs in Two Drug Businesses
Some affected employees are likely to be assigned to other roles. Some eliminated positions involved selling Breztri, an asthma medicine.
AstraZeneca eliminated about 600 marketing positions spanning its respiratory and immunology businesses. Some employees affected by the cuts are likely to be assigned to other roles at the company.
Some eliminated positions involved selling Breztri, an asthma medicine containing budesonide, glycopyrrolate and formoterol.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.